OptymEdge hires Senior Director to Drive Global Roll-Out of ACUVERA Platform

Oklahoma’s Largest Locally Owned Health Plan Selects 1upHealth as a Strategic Interoperability Partner

Clearwater Receives Strategic Growth Investment from Sunstone Partners

ZeOmega Named Leader in Everest Group’s PEAK® Matrix Assessment for Second Consecutive Year

Symbiosis Expands Sterile Manufacturing Capacity with Fill/Finish Line Qualification 

P&C Labs Achieves Immediate Efficiency Gains with Proscia’s Software

Pathologists readily embrace the shift to digital workflows.

Hovione and Microinnova partner to advance modular flow chemistry for multi-purpose manufacturing

Proscia to Expand Pathology AI Capabilities with Virtual Staining

Delivering a menu of H&E, IHC, and special stains on the Concentriq platform

PubHive Introduces Generative AI Usage Dashboard to Advance Governance and Cost Efficiency in Life Sciences

PubHive launches Generative AI Usage Dashboard to give life sciences teams visibility, compliance, and cost control for responsible AI adoption.

Ambience Healthcare Launches Real-Time HCC Compliance Validator to Reduce Audit Risk and Strengthen Documentation Integrity

Takara Bio Europe Launches Cellartis® MSC EV Wonder™, a Defined, Xeno-Free Medium for High-Yield EV Production

Takara Bio Europe announces the launch of Cellartis® MSC EV Wonder.

Arkivum announces new partnership with unified trial management platform provider PHARMASEAL

Arkivum is delighted to announce a new partnership with PHARMASEAL, the provider of the Engility® Trial Management Platform, consisting of a Clinical Trial Management System (CTMS) and Electronic Trial Master File (eTMF).

Abselion Introduces Protein G Total Antibody Quantification Kit

New kit enables rapid, accurate titre measurement across broad range of IgG subclasses and species on Amperia platform

Huateng Pharma Highlights Key Intermediate for Aficamten

Hunan Huateng Pharmaceutical Co., Ltd. provides 1-Methyl-1H-Pyrazole-4-Carboxylic Acid (CAS 5952-92-1), a high-purity intermediate used in the synthesis of Aficamten (CK-274), an investigational cardiac myosin inhibitor currently in Phase 3 trials for hypertrophic cardiomyopathy.

Lindus Health and Frieda Health Successfully Complete Clinical Trial Evaluating Novel Treatment for Menopause Symptoms

Lindus Health and Frieda Health Successfully Complete Clinical Trial Evaluating Novel Treatment for Menopause Symptoms

Ardent Health Announces Enterprise Rollout of Ambience Healthcare's AI Platform for Documentation, Coding and Clinical Workflows

Carolina Molecular Inc. and Astoriom to Collaborate on Integrated Molecular Testing and Biospecimen Storage Services

Research Triangle Park-based companies provide comprehensive testing and sample storage to CROs, CDMOs, Pharma and Biotech Partners

BMJ Group report reveals digital health expectation gap, with healthcare professionals left waiting for productivity gains

Proscia Expands AWS Collaboration to Advance Precision Medicine with AWS HealthImaging Integration

AWS HealthImaging integration delivers standards-based digital pathology at enterprise scale with DICOM and Proscia’s cloud-native platform

FUJIFILM Biosciences Introduces BalanCD HEK293 Perfusion A Medium to Enable Gene Therapy Production

• First commercially available cell culture solution for HEK293 cells and perfusion -– optimized for high cell density (HCD), intensified processes and perfusion cultures • Additional capabilities for continuous Adeno-Associated Virus (AAV) and Lentivirus (LV) production for consistent quality, performance, and scalability